Partner Investment Management’s bluebird bio BLUE Stock Holding History

Partner Investment Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-135	Closed	-$298K	–	111
2018 Q1	$298K	Sell	135 -17	-11%	-$43.2K	0.32%	69
2017 Q4	$350K	Buy	+152	New	+$309K	0.4%	61
2016 Q1	–	Sell	-867	Closed	-$721K	–	80
2015 Q4	$721K	Buy	+867	New	+$866K	1.18%	32
2015 Q3	–	Sell	-221	Closed	-$482K	–	76
2015 Q2	$482K	Sell	221 -65	-23%	-$132K	0.68%	52
2015 Q1	$447K	Sell	286 -514	-64%	-$678K	0.67%	58
2014 Q4	$950K	Buy	+800	New	+$535K	0.39%	54
2014 Q2	–	Sell	-884	Closed	-$260K	–	64
2014 Q1	$260K	Buy	884 +167	+23%	+$50.6K	0.05%	65
2013 Q4	$195K	Buy	717 +247	+53%	+$69K	0.04%	59
2013 Q3	$164K	Buy	+470	New	+$175K	0.04%	65

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Partner Investment Management's BLUE Position: Q2 2018 in Review

Partner Investment Management sold out of bluebird bio (BLUE) in Q2 2018, closing a stake of 135 shares — an estimated $298K sold.

Partner Investment Management first reported a position in BLUE in Q3 2013 and held it in 9 quarters. The position peaked at $950K in Q4 2014. 307 funds tracked by Wall St. Rank hold BLUE as of Q2 2018.

Partner Investment Management reported no remaining bluebird bio position as of Q2 2018 after selling out during the quarter.
Partner Investment Management sold 135 bluebird bio shares in Q2 2018, an estimated $298K.
Partner Investment Management first reported a position in bluebird bio in Q3 2013 and held it in 9 quarters.
Partner Investment Management's bluebird bio position peaked at $950K in Q4 2014.
307 funds tracked by Wall St. Rank held bluebird bio as of Q2 2018.

Based on Partner Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.